Patents Assigned to Fallien Cosmeceuticals, Ltd.
  • Patent number: 8911754
    Abstract: The present application relates to sunscreen formulations, including foamable sunscreen formulations, that comprise zinc oxide and titanium dioxide particles, suitably in the size range of about 1-100 nm. The compositions suitably produce a minimal residual whitening effect when applied to a skin surface.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: December 16, 2014
    Assignee: Fallien Cosmeceuticals, Ltd.
    Inventors: David J. Milora, Harry Fallick
  • Patent number: 8795696
    Abstract: The present application relates to sunscreen formulations, including foamable sunscreen formulations, that comprise zinc oxide and titanium dioxide particles, suitably at least 5 wt % of which have a primary particle size of greater than about 100 nm. The compositions also comprise pigments and suitably produce a minimal residual whitening effect when applied to a skin surface.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: August 5, 2014
    Assignee: Fallien Cosmeceuticals, Ltd.
    Inventors: David J. Milora, Harry Fallick
  • Patent number: 5945447
    Abstract: A topical preparation containing about 5 to 15% by weight of ascorbic acid; about 5 to 15% by weight of water; a mixture of high and low molecular weight polyethylene glycol and silicone or vegetable oil. The preparation is placed into a package in unit dosage form under the atmosphere of an inert gas so as to be substantially free of oxygen.
    Type: Grant
    Filed: January 26, 1998
    Date of Patent: August 31, 1999
    Assignee: Fallien Cosmeceuticals Ltd
    Inventor: Harry Fallick
  • Patent number: 5256140
    Abstract: The invention provides a method for preparing an injectable skin extract for use in levelling skin having depressions. The method provides for the steps of excising skin from a patient, cooling the skin to make it brittle, pulverizing the brittle skin, extracting collagen from the pulverized skin with an acid solution, evaporating off the acid and then solubilizing the resulting powder to form an injectable.
    Type: Grant
    Filed: March 27, 1992
    Date of Patent: October 26, 1993
    Assignee: Fallien Cosmeceuticals, Ltd.
    Inventor: Harry Fallick